We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
-4.92%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$5.95B
AUM Growth
-$1.04B
Cap. Flow
-$663M
Cap. Flow %
-11.14%
Top 10 Hldgs %
61.43%
Holding
140
New
12
Increased
47
Reduced
48
Closed
9

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$26.5M
2
TEVA icon
Teva Pharmaceuticals
TEVA
+$7.49M
3
CI icon
Cigna
CI
+$6.85M
4
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$4.9M
5
RARE icon
Ultragenyx Pharmaceutical
RARE
+$4.58M

Top Sells

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$123M
2
HDB icon
HDFC Bank
HDB
+$78.3M
3
V icon
Visa
V
+$71.4M
4
GILD icon
Gilead Sciences
GILD
+$42M
5
DIS icon
Walt Disney
DIS
+$38.2M

Sector Composition

Rank Sector Weight
1 Financials 33.21%
2 Healthcare 25.04%
3 Communication Services 16.03%
4 Consumer Discretionary 12.69%
5 Industrials 5.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSM icon
51
TSMC
TSM
$2T
$4.94M 0.08%
238,160
+51,100
+27% +$1.07M
CERN
52
DELISTED
Cerner Corp
CERN
$4.84M 0.08%
80,678
+600
+0.7% +$39.2K
TVRD
53
Tvardi Therapeutics
TVRD
$22.3M
$4.83M 0.08%
9,391
+1,423
+18% +$953K
TTPH
54
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$4.67M 0.08%
31,276
+6,676
+27% +$4.9M
DVAX
55
DELISTED
Dynavax Technologies
DVAX
$4.6M 0.08%
187,522
+30,560
+19% +$865K
EXAS
56
DELISTED
Exact Sciences
EXAS
$4.5M 0.08%
250,000
+30,000
+14% +$689K
NUVA
57
DELISTED
NuVasive, Inc.
NUVA
$4.49M 0.08%
93,160
+5,000
+6% +$258K
DXCM icon
58
DexCom
DXCM
$29.2B
$4.29M 0.07%
199,700
-100,000
-33% -$2.23M
SUPN icon
59
Supernus Pharmaceuticals
SUPN
$2.69B
$4.07M 0.07%
290,000
– –
LDRH
60
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
$4.04M 0.07%
116,917
– –
MDVN
61
DELISTED
MEDIVATION, INC.
MDVN
$3.92M 0.07%
92,262
+4,540
+5% +$225K
RARE icon
62
Ultragenyx Pharmaceutical
RARE
$2.5B
$3.85M 0.06%
+40,000
New +$4.58M
RLYP
63
DELISTED
RELYPSA INC COM
RLYP
$3.71M 0.06%
200,360
+60,360
+43% +$1.66M
IONS icon
64
Ionis Pharmaceuticals
IONS
$8.99B
$3.68M 0.06%
91,060
+360
+0.4% +$18.6K
MDXG icon
65
MiMedx Group
MDXG
$660M
$3.67M 0.06%
380,000
– –
NVDQ
66
DELISTED
Novadaq Technologies Inc.
NVDQ
$3.65M 0.06%
350,000
+100,000
+40% +$1.18M
AERI
67
DELISTED
Aerie Pharmaceuticals
AERI
$3.57M 0.06%
201,350
-125,153
-38% -$2.27M
ACHC icon
68
Acadia Healthcare
ACHC
$2.56B
$3.31M 0.06%
50,000
– –
PTLA
69
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$3.28M 0.06%
77,013
– –
SPNC
70
DELISTED
Spectranetics Corp
SPNC
$3.23M 0.05%
273,956
+120,000
+78% +$2.15M
ONCE
71
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$3.22M 0.05%
77,220
+15,220
+25% +$794K
ZVRA icon
72
Zevra Therapeutics
ZVRA
$576M
$3.2M 0.05%
+10,313
New +$3.16M
KTWO
73
DELISTED
K2M Group Holdings, Inc
KTWO
$3.18M 0.05%
171,151
+70,000
+69% +$1.53M
ATHN
74
DELISTED
Athenahealth, Inc.
ATHN
$3.1M 0.05%
23,222
+2,000
+9% +$261K
INNL
75
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$3.07M 0.05%
245,184
– –
1 2
3
4 5

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q3 2015 Portfolio in Review

As of Q3 2015, C WorldWide Group held 140 positions worth $5.95B, down 15% from $6.99B the previous quarter. Its ten largest holdings account for 61% of the portfolio.

C WorldWide Group withdrew a net $663M in Q3 2015, closing 9 positions and reducing 48 holdings. Its most notable exit was Zimmer Biomet, an estimated $8.68M position sold in full.

By sector, the portfolio is most concentrated in Financials at 33% of assets, down from 34% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, C WorldWide Group opened a new position in Ultragenyx Pharmaceutical worth $3.85M.

  • C WorldWide Group's largest Q3 2015 buy was Ultragenyx Pharmaceutical: 40,000 shares worth $3.85M.
  • C WorldWide Group added most to McKesson in Q3 2015, an estimated $26.5M increase.
  • C WorldWide Group's biggest Q3 2015 reduction was Alphabet (Google) Class C, cutting an estimated $123M.
  • C WorldWide Group fully exited Zimmer Biomet in Q3 2015, selling an estimated $8.68M.
  • C WorldWide Group's ten largest holdings make up 61% of its $5.95B portfolio in Q3 2015.
  • C WorldWide Group opened 12 new positions and closed 9 in Q3 2015.
  • C WorldWide Group's portfolio value fell 15% quarter-over-quarter to $5.95B.

Based on C WorldWide Group's 13F filing for Q3 2015, filed 12 Nov 2015.